Henry Schein Inc. (HSIC)
NASDAQ: HSICHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
HSIC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $9.23B
- P/E (TTM)
- 22.88
- Forward P/E
- 13.91
- EPS (TTM)
- $3.65
- Dividend yield
- None
- 52-week range
- 68.70 – 92.18
- Day range
- 83.20 – 86.31
- Volume / Avg
- 1.31M / 1.33M
- Beta
- —
- Shares outstanding
- 110.54M
52-week range
HSIC stock today
Henry Schein (HSIC) closed at $83.52 on Nov 20, down 1.51% (-$1.28), versus the S&P 500's 3.70% decline. Shares are 9.4% below their 52-week high of $92.18, set on Aug 4, 2026 and 21.6% above the 52-week low of $68.70, in the middle of the past year's range. HSIC is up 10.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 13.8%.
At 22.9x trailing earnings, Henry Schein trades in line with the peer-group median of 24.8x. Its forward P/E of 13.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Henry Schein
Company profileHenry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Andrea Albertini
- Headquarters
- Melville, NY
- Employees
- 25,000
- IPO year
- 1995
- Website
- henryschein.com
Financial highlights
Full financialsIn fiscal 2025, Henry Schein generated $13.18 billion in revenue, up 4.0% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $398.0 million (+2.1% year over year), for a net margin of 3.0% versus a median of 4.0% in the prior 5 years. Gross margin was 31.1% (down from 31.7%) and operating margin 5.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Growth | +4.03% | +2.71% | -2.44% | +1.98% | +22.55% |
| Net income | $398.00M | $390.00M | $416.00M | $538.00M | $631.00M |
| EPS (diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
Analyst forecast
ForecastConsensus (16 analysts)
buy
Avg. price target
$96.87+15.98%
- Strong buy 4
- Buy 4
- Hold 7
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $1.06 vs $1.34
- Surprise
- -20.90%
HSIC news
All HSIC news- Henry Schein, Inc. (HSIC) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha
- Henry Schein, Inc. Updates Non-GAAP Financial Measures Presentation and Adjusts 2026 GuidanceNasdaq
- Axxess Partners With Henry Schein Home Solutions to Simplify Access to Medical Supplies and Equipment for ClientsPR Newswire
- Is Henry Schein (HSIC) a Solid Growth Stock? 3 Reasons to Think "Yes"Nasdaq
- Henry Schein (HSIC) Upgraded to Buy: What Does It Mean for the Stock?Nasdaq
- HSIC vs. MMSI: Which Stock Should Value Investors Buy Now?NasdaqHSIC, MMSI
- Here's Why Henry Schein (HSIC) is a Strong Growth StockNasdaq
- Is Henry Schein (HSIC) Stock Undervalued Right Now?Nasdaq
Henry Schein peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MOHMolina Healthcare Inc | 198.39 | -2.43% | $10.36B | vs HSIC |
| OSCROscar Health Inc. Class A | 24.73 | -5.50% | $7.68B | vs HSIC |
| RDNTRadNet Inc. | 69.71 | +0.29% | $5.49B | vs HSIC |
| CONConcentra Group Holdings Parent Inc. | 41.84 | +0.94% | $5.26B | vs HSIC |
| CAICaris Life Sciences Inc. | 17.58 | -5.18% | $5.04B | vs HSIC |
| GRALGRAIL Inc. | 99.25 | -5.33% | $4.46B | vs HSIC |
| BLLNBillionToOne Inc. Class A | 89.92 | -0.31% | $4.30B | vs HSIC |
| CDNACareDx Inc. | 70.00 | -2.67% | $3.68B | vs HSIC |
Indexes, lists and sector
Index membership
Henry Schein stock FAQ
What is Henry Schein's stock price today?
HSIC last traded at $83.52 as of Nov 20, 4:00 PM EST, down 1.51% on the day. Prices are delayed at least 15 minutes.
Does Henry Schein pay a dividend?
No. Henry Schein does not currently pay a regular cash dividend.
What is HSIC's P/E ratio?
HSIC trades at a trailing P/E ratio of 22.88 and a forward P/E of 13.91, compared with a median of 24.8 for its closest peers.
Is Henry Schein in the S&P 500?
Yes. Henry Schein (HSIC) is a constituent of the S&P 500 index.
Who is Henry Schein's CEO?
Mr. Andrea Albertini is the chief executive officer of Henry Schein Inc., which has about 25,000 employees.
Has HSIC ever split its stock?
Yes. The most recent HSIC stock split was a 1275-for-1000 split on Feb 8, 2019, one of 3 splits on record.
What is the HSIC 52-week high?
The 52-week high for HSIC is $92.18 and the 52-week low is $68.70. The stock is currently 9.4% below its high.